More Articles


Best of Both Worlds

Adam Hill, (Jun 5, 2017)

Can pharma deliver both patient value and shareholder value?

Trust Me, I'm a Pharmaceutical Company

Hugh Gosling, (Jun 1, 2017)

Award-winning YouTube channel offering impartial health information is truly patient-centric
Market Access

When the Machines Take Over

Deirdre Coleman, (May 30, 2017)

How technology is making the world's health data useful

Bringing the Clinical Trial to the Patient

Danielle Barron, (May 26, 2017)

In-home visits are making clinical trials more convenient for patients - and more productive for research companies

A Defining Moment

Danielle Barron, (May 24, 2017)

AstraZeneca is going back to basics by publishing a definition of patient centricity, moving the focus from what a company does to how it does it
Market Access

What the FDA Really Thinks About Real-World Evidence

Deirdre Coleman, (May 19, 2017)

Real-world evidence is a critical issue for the FDA, but we must work together to ensure it meets the highest possible standards, says former FDA Commissioner, Robert Califf
Market Access

Towards A New Era in Oncology

Danielle Barron, (May 19, 2017)

Companies must demonstrate meaningful clinical outcomes to guarantee access to their medicines, says Patricia Andrews, the new CEO of Boston Biomedical

Up In The Air With IBD

Hugh Gosling, (May 18, 2017)

An award-winning project spearheaded by Takeda is making it easier for patients to FlyWithIBD

Fixing Pharma's Broken Commercial Model

Katie Osborne, (May 15, 2017)

In an ever-more complex pharma landscape, a focus on patients and patient outcomes is the safest route to commercial success, say four top pharma executives.

Boehringer Aims High with Angels Initiative

Danielle Barron, (Apr 25, 2017)

An ambitious scheme to save 100,000 lives is the runaway winner at the eyeforpharma awards